Variables | Infected recipients (55) | Uninfected recipients (152) | P value |
---|---|---|---|
Univariate analysis | Â | Â | Â |
Female | 16 | 19 | 0.005 |
Age ≥ 50 years | 28 | 49 | 0.014 |
Preoperative MELD score ≥ 25 | 33 | 71 | 0.091 |
Length of hospital stay before LT ≥ 7 days | 34 | 82 | 0.314 |
Antibiotic use within 15 days before LT | 21 | 47 | 0.326 |
Hepatitis B cirrhosis/liver necrosis/liver cancer | 40 | 116 | 0.597 |
Alcoholic cirrhosis | 4 | 10 | 1 |
Preoperative type 2 diabetes | 9 | 18 | 0.394 |
Infection within 2 months before LT | 31 | 68 | 0.139 |
Preoperative WBC ≤ 4 × 109/L | 13 | 54 | 0.106 |
Preoperative lymphocyte count < 0.5 × 109/L | 9 | 42 | 0.097 |
Preoperative platelet count < 50 × 109/L | 16 | 54 | 0.387 |
Preoperative albumin ≤ 30 g/L | 17 | 27 | 0.041 |
Cold ischemia time of donor > 360 min | 25 | 70 | 0.939 |
Duration of operation ≥ 400 min | 27 | 42 | 0.004 |
The intraoperative blood loss ≥ 3000ml | 40 | 76 | 0.004 |
The intraoperative RBC transfusion ≥ 12U | 37 | 82 | 0.087 |
Basiliximab ≥ 40 mg | 32 | 77 | 0.338 |
Antithymocyte globulin | 5 | 9 | 0.625 |
Methylprednisolone > 1500 mg | 31 | 90 | 0.714 |
ALT on day 1 after LT > 1000U/L | 22 | 41 | 0.2 |
Serum creatinine on day 3 after LT > 1.5 mg/dL | 9 | 25 | 0.989 |
Postoperative ventilator support | 8 | 8 | 0.027 |
Reoperation | 3 | 4 | 0.577 |
Acute rejection | 4 | 22 | 0.167 |